These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37402864)

  • 1. Impaired vision in children prenatally exposed to methadone: an observational cohort study.
    Hamilton R; Mulvihill A; Butler L; Chow A; Irving E; McCulloch DL; McNeil A; Michael K; Spowart KM; Waterson-Wilson J; Mactier H
    Eye (Lond); 2024 Jan; 38(1):118-126. PubMed ID: 37402864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
    Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
    Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
    Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual function in Norwegian children aged 5-13 years with prenatal exposure to opioid maintenance therapy: A case-control study.
    Aslaksen AK; Vikesdal GH; Voie MT; Rowlands M; Skranes J; Haugen OH
    Acta Ophthalmol; 2024 Jun; 102(4):409-420. PubMed ID: 37702266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
    Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
    Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
    Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
    Mactier H; McLaughlin P; Gillis C; Osselton MD
    Am J Perinatol; 2017 Jul; 34(9):918-921. PubMed ID: 28320034
    [No Abstract]   [Full Text] [Related]  

  • 11. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
    Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
    Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring.
    Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US
    Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes.
    Jansson LM; Di Pietro JA; Elko A; Williams EL; Milio L; Velez M
    Drug Alcohol Depend; 2012 May; 122(3):213-9. PubMed ID: 22041255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health and Neurodevelopment of Children Born to Opioid-Dependent Mothers at School Entry.
    Lee SJ; Pritchard VE; Austin NC; Henderson JMT; Woodward LJ
    J Dev Behav Pediatr; 2020 Jan; 41(1):48-57. PubMed ID: 31393318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry.
    Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK
    Elife; 2021 Mar; 10():. PubMed ID: 33724184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.
    Kaltenbach K; O'Grady KE; Heil SH; Salisbury AL; Coyle MG; Fischer G; Martin PR; Stine S; Jones HE
    Drug Alcohol Depend; 2018 Apr; 185():40-49. PubMed ID: 29413437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
    Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
    JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
    McQueen KA; Murphy-Oikonen J; Desaulniers L
    Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.